Loading data
CRNCNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 251.78 m USD | 331.5 m USD | 294.48 m USD | 327.89 m USD |
| Cost of revenue | 68.65 m USD | 87.23 m USD | 95.16 m USD | 97.17 m USD |
| Gross profit | 183.14 m USD | 244.27 m USD | 199.31 m USD | 230.72 m USD |
| Research and development expense | 97.76 m USD | 121.56 m USD | 123.33 m USD | 107.12 m USD |
| Operating profit | -2.29 m USD | -579.94 m USD | -27.2 m USD | -184.35 m USD |
| Interest expense | — | 12.55 m USD | 14.77 m USD | 14.39 m USD |
| Profit before tax | -8.82 m USD | -584.61 m USD | -36.39 m USD | -198.75 m USD |
| Income tax expense | 9.89 m USD | 3.47 m USD | 19.87 m USD | 112.08 m USD |
| Net income (reported basis) | -18 m USD | -588 m USD | -56 m USD | -311 m USD |
| Basic earnings per share | -0.43 USD/share | -14.12 USD/share | -1.4 USD/share | -7.93 USD/share |
| Diluted earnings per share | -0.43 USD/share | -14.12 USD/share | -1.4 USD/share | -7.93 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.